Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway

Yanbin Zhang(University of Miami), Xiaobing Jiang(Huazhong University of Science and Technology)
Aging
June 26, 2024
Cited by 0


Related Papers